Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT07409194

The Effect of Acupressure on Hyperbilirubinemia in Newborns: A Randomized Controlled Trial

Conditions: Hyperbilirubinemia

Sex: All
Ages: 38 Weeks – 42 Months
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Yuzuncu Yil University

Location: Van Yuzuncu Yil University Van

Summary

This study is a randomized controlled trial conducted to evaluate the effect of acupressure application on hyperbilirubinemia in newborns. The study examined the effect of regular acupressure applications to specific points on serum bilirubin levels in newborns at risk of developing physiological jaundice in the first days of life. By comparing bilirubin levels between the experimental and control groups, the potential benefits of acupressure in reducing the severity of jaundice and supporting bilirubin metabolism were investigated. The findings suggest that acupressure can be used as a complementary method in neonatal care.

Eligibility Criteria

Inclusion Criteria: * Gestational age ≥38 weeks * Diagnosed with neonatal hyperbilirubinemia * Hospitalized in the neonatal unit for at least 24 hours * Birth weight ≥2500 g * Written informed consent obtained from parents Exclusion Criteria: * Preterm newborns * Congenital metabolic disease or congenital anomalies * Hemodynamically unstable newborns * Newborns whose parents did not provide consent * Newborns with any condition preventing acupressure application

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07409194). StuddyBuddy aggregates publicly available trial information.